These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 18521498)

  • 1. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
    Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
    Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the safety profiles of two low-molecular-weight heparins.
    Ofosu FA
    Thromb Haemost; 2008 Jun; 99(6):989-90. PubMed ID: 18521496
    [No Abstract]   [Full Text] [Related]  

  • 4. Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.
    Zufferey PJ; Samama CM; Rosencher N
    Thromb Haemost; 2010 Dec; 104(6):1083-4. PubMed ID: 20886198
    [No Abstract]   [Full Text] [Related]  

  • 5. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
    Schulman S
    Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin.
    Paciaroni M; Ageno W; Agnelli G
    Thromb Haemost; 2008 May; 99(5):978-80. PubMed ID: 18449438
    [No Abstract]   [Full Text] [Related]  

  • 7. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
    Diener HC
    MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent venous thromboembolism: quite harmless after all?
    Konstantinides SV
    Thromb Haemost; 2008 Apr; 99(4):655-6. PubMed ID: 18392321
    [No Abstract]   [Full Text] [Related]  

  • 11. Letters on management of ischemic stroke.
    Porat G
    Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038
    [No Abstract]   [Full Text] [Related]  

  • 12. Bleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery.
    Kistler U; Kramers-de Quervain I; Munzinger U; Kucher N
    Thromb Haemost; 2008 Jun; 99(6):1049-52. PubMed ID: 18521507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism.
    Strom RG; Frempong-Boadu AK
    Spine (Phila Pa 1976); 2013 Nov; 38(23):E1498-502. PubMed ID: 23873245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
    J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VTE primary prevention, including hospitalised medical and orthopaedic surgical patients.
    Granziera S; Cohen AT
    Thromb Haemost; 2015 Jun; 113(6):1216-23. PubMed ID: 25809340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual risk assessment is the best strategy for thromboembolic prophylaxis.
    Caprini JA
    Dis Mon; 2010 Oct; 56(10):552-9. PubMed ID: 20971324
    [No Abstract]   [Full Text] [Related]  

  • 19. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Dec; (8):209-24. PubMed ID: 12603878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.